We are live on ! Find out more
NSEDCP

NJ State Employees Deferred Compensation Plan Portfolio holdings

AUM $906M
1-Year Est. Return 24.85%
This Fund
S&P 500
This Quarter Est. Return
+16.04%
1 Year Est. Return
+24.85%
3 Year Est. Return
+127.22%
5 Year Est. Return
+201.43%
10 Year Est. Return
+564.84%
AUM
$550M
AUM Growth
+$69.7M
Cap. Flow
+$1.12M
Cap. Flow %
0.2%
Top 10 Hldgs %
19.3%
Holding
562
New
46
Increased
72
Reduced
103
Closed
24

Top Buys

Rank Stock Value
1
S
Sprint Corporation
S
+$2.48M
2
CELG
Celgene Corp
CELG
+$1.05M
3
ABT icon
Abbott
ABT
+$1.04M
4
CVS icon
CVS Health
CVS
+$741K
5
AGN
Allergan plc
AGN
+$725K

Top Sells

Rank Stock Value
1
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
+$1.97M
2
PFE icon
Pfizer
PFE
+$1.6M
3
IONS icon
Ionis Pharmaceuticals
IONS
+$1.16M
4
MRK icon
Merck
MRK
+$1.02M
5
ZTS icon
Zoetis
ZTS
+$999K

Sector Composition

Rank Sector Weight
1 Technology 19.73%
2 Financials 15.47%
3 Industrials 12.95%
4 Healthcare 12.28%
5 Consumer Discretionary 8.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VZ icon
26
Verizon
VZ
$195B
$3.84M 0.7%
65,000
– –
MCD icon
27
McDonald's
MCD
$192B
$3.63M 0.66%
19,093
– –
RTX icon
28
RTX Corp
RTX
$290B
$3.61M 0.66%
44,495
– –
GOOGL icon
29
Alphabet (Google) Class A
GOOGL
$4.36T
$3.39M 0.62%
57,600
– –
LOW icon
30
Lowe's Companies
LOW
$117B
$3.28M 0.6%
30,000
– –
ALL icon
31
Allstate
ALL
$68B
$3.18M 0.58%
33,810
– –
HON icon
32
Honeywell
HON
$77B
$3.18M 0.58%
21,220
– –
LLY icon
33
Eli Lilly
LLY
$1.02T
$3.11M 0.57%
23,960
-1,040
-4% -$126K
TRV icon
34
Travelers Companies
TRV
$78.1B
$3.08M 0.56%
22,443
– –
T icon
35
AT&T
T
$159B
$3.06M 0.56%
129,340
– –
KO icon
36
Coca-Cola
KO
$377B
$3.05M 0.55%
65,000
– –
COP icon
37
ConocoPhillips
COP
$147B
$3M 0.55%
45,000
– –
COST icon
38
Costco
COST
$422B
$2.91M 0.53%
12,000
– –
GS icon
39
Goldman Sachs
GS
$300B
$2.88M 0.52%
15,000
– –
ITW icon
40
Illinois Tool Works
ITW
$82.6B
$2.87M 0.52%
20,000
– –
PEP icon
41
PepsiCo
PEP
$190B
$2.85M 0.52%
23,251
– –
IBM icon
42
IBM
IBM
$211B
$2.82M 0.51%
20,920
– –
CL icon
43
Colgate-Palmolive
CL
$73.1B
$2.74M 0.5%
40,000
– –
PFE icon
44
Pfizer
PFE
$143B
$2.72M 0.49%
67,410
-40,052
-37% -$1.6M
NSC icon
45
Norfolk Southern
NSC
$75.4B
$2.71M 0.49%
14,500
– –
LIN icon
46
Linde
LIN
$221B
$2.64M 0.48%
15,000
– –
BAC icon
47
Bank of America
BAC
$435B
$2.62M 0.48%
95,082
– –
TROW icon
48
T. Rowe Price
TROW
$23.9B
$2.6M 0.47%
26,000
– –
PYPL icon
49
PayPal
PYPL
$48.9B
$2.6M 0.47%
25,000
– –
MRSH
50
Marsh
MRSH
$90.5B
$2.54M 0.46%
27,000
– –
1
2
3 4 5

Similar funds

IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
BFS
Bard Financial Services Branford, Connecticut $911M AUM 19.14% 1-Year Est. Return
MSAM
Moloney Securities Asset Management Manchester, Missouri $840M AUM 18.11% 1-Year Est. Return
SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return
CP
Coho Partners Berwyn, Pennsylvania $779M AUM 4.46% 1-Year Est. Return
EAM
EFG Asset Management Portland, Oregon $773M AUM 40.1% 1-Year Est. Return
HWM
Hemington Wealth Management Falls Church, Virginia $769M AUM 13.16% 1-Year Est. Return
BVDMP
Bedrijfstakpensioenfonds Voor De Media PNO Hilversum, Netherlands $759M AUM 19.37% 1-Year Est. Return

NJ State Employees Deferred Compensation Plan's Q1 2019 Portfolio in Review

As of Q1 2019, NJ State Employees Deferred Compensation Plan held 562 positions worth $550M, up 15% from $480M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

NJ State Employees Deferred Compensation Plan's Q1 2019 filing shows 46 new, 72 increased, 103 reduced and 24 closed positions. Its largest new stake was Allergan plc: 5,000 shares worth $732K. The largest sale was Twenty-First Century Fox, Inc. Class A, an estimated $1.97M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Industrials.

  • NJ State Employees Deferred Compensation Plan's largest Q1 2019 buy was Allergan plc: 5,000 shares worth $732K.
  • NJ State Employees Deferred Compensation Plan added most to Sprint Corporation in Q1 2019, an estimated $2.48M increase.
  • NJ State Employees Deferred Compensation Plan's biggest Q1 2019 reduction was Pfizer, cutting an estimated $1.6M.
  • NJ State Employees Deferred Compensation Plan fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $1.97M.
  • NJ State Employees Deferred Compensation Plan's ten largest holdings make up 19% of its $550M portfolio in Q1 2019.
  • NJ State Employees Deferred Compensation Plan opened 46 new positions and closed 24 in Q1 2019.
  • NJ State Employees Deferred Compensation Plan's portfolio value rose 15% quarter-over-quarter to $550M.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q1 2019, filed 1 May 2019.